Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
p53 biomarker
Biotech
PMV sidelines 2 programs as lead tumor suppressor picks up pace
PMV has pressed pause on two preclinical tumor candidates to funnel all resources into getting its lead precision oncology med through the clinic.
James Waldron
Mar 1, 2023 12:00pm
Vanderbilt team offers new clues for targeting p53
Sep 1, 2021 9:50am
Stopping cancer cells by blocking a growth-promoting protein
Aug 9, 2021 10:00am
Improving I-O by reactivating the 'guardian of the genome'
Jul 7, 2021 9:10am
How a protein promotes pancreatic cancer metastasis
Aug 7, 2020 5:47am
Bypassing p53 to enable CRISPR editing in blood disorders
Mar 22, 2019 9:36am
